Advertisement

Reactions Weekly

, Volume 1734, Issue 1, pp 295–295 | Cite as

Ipilimumab/nivolumab/pembrolizumab

Various toxicities: 38 case reports
Case report
  • 8 Downloads

Reference

  1. Moreira A, et al. Myositis and neuromuscular side-effects induced by immune checkpoint inhibitors. European Journal of Cancer 106: 12-23, Jan 2019. Available from: URL: http://doi.org/10.1016/j.ejca.2018.09.033 - Germany

Copyright information

© Springer Nature Switzerland AG 2019

Personalised recommendations